arrow
返回
H

Haitao Zhao

peking union medical college hospital

58H指数
554论文数
1.5W被引数
收录论文 246
发表时间
Applications and advances of bile-based omics technologies in the diagnosis of cholangiocarcinoma胆汁组学技术在胆管癌诊断中的应用与进展
err2026-09-19
err0
PREAI
errTaifeng Zhu; Jiali Xing; Ziyue Huang; Shanshan Wang; Duo Li; Xinting Sang; Cong Ning; Chengpei Zhu; Yongchang Zheng; Haitao Zhao
err分享
err收藏
Biomimetic Scaffold-Based 3D Models for Decoding Cancer Biology and Advancing Therapy基于仿生支架的3D模型用于解析癌症生物学和推进治疗
err2026-09-17
err0
errOAAI
errHaitao Zhao; Yuechen Han; Jie Li; Peng Luo; Lin Qi; Zhiwei Xia; Xiaosong Li; Quan Cheng; Chenshen Huang; Wantao Wu; Hao Zhang
err分享
err收藏
Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRASG12D mutations: a phase 1 trial口服KRAS G12D抑制剂GFH375用于既往治疗过的KRASG12D突变晚期实体瘤:一项1期临床试验
err2026-09-15
err0
PREAI
errXinghao Ai; Zhengbo Song; Lin Wu; Aiping Zhou; Di Cheng; Hong Zong; Heshui Wu; Zuoxing Niu; Yuping Sun; Lingjun Zhu; Zhiwei Li; Yanhong Deng; Ying Yuan; Xiujuan Qu; Haitao Zhao; Yingying Du; Ziming Li; Yu Wang; Haige Shen; Huaqiang Zhu; Chanli Zheng; Shuang Wang; Zhao Cui; Lingyu Tai; Shun Lu
err分享
err收藏
err分享
err收藏
Integrated single-cell multi-omics characterization reveals lipid-associated macrophage-mediated immunosuppression in neoadjuvant immunotherapy of hepatocellular carcinoma整合单细胞多组学表征揭示肝癌新辅助免疫治疗中脂质相关巨噬细胞介导的免疫抑制
err2026-07-31
err0
errOAAI
errShengxuan Peng; Chang Liu; Junyu Long; Jincheng Tian; Han Li; Donghai Lu; Qihang Cao; Daolin Zhang; Qiao He; Jisen Jia; Yuxuan Wang; Zhaoru Dong; Haitao Zhao; Lei Zhao; Dongxu Wang; Tao Li
err分享
err收藏
Effectiveness and safety of PD-1/PD-L1 inhibitors plus lenvatinib with or without Gemox chemotherapy in advanced intrahepatic cholangiocarcinomaPD-1/PD-L1抑制剂联合仑伐替尼(有无吉西他滨化疗)在晚期肝内胆管癌中的有效性与安全性
err2026-07-16
err0
errOAAI
errShuofeng Li; Guanhua Yu; Shanshan Wang; Mingming Wang; Chengpei Zhu; Mingjian Piao; Ziyu Xun; Chengjie Li; Boyu Sun; Jiashuo Chao; Jie Pan; Kang Zhou; Xinyuan Chen; Xiaobo Yang; Haitao Zhao
err分享
err收藏
Lenvatinib enhances the response of biliary tract cancer to anti-HER2 therapy仑伐替尼增强胆道癌对HER2靶向治疗的反应
err2026-07-08
err0
errOAAI
errHuishan Sun; Shuofeng Li; Zhe Zhu; Guanhua Yu; Ziyue Huang; Nan Zhang; Shi Feng; Yiran Li; Cong Ning; Ziyu Xun; Jingnan Xue; Dandan Li; Longhao Zhang; Mingjian Piao; Chengjie Li; Jiongyuan Li; Boyu Sun; Xiaobo Yang; Hanping Wang; Haitao Zhao
err分享
err收藏
Peripheral PD-1⁺ T Cell Signatures Predict Immunotherapy Response and Survival in Hepatobiliary Cancers
err2026-01-22
err0
errOAAI
errMingjian Piao; Jiayu Xiao; Nan Zhang; Chengjie Li; Jiongyuan Li; Lihua Guan; Shuofeng Li; Zhe Zhu; Shi Feng; Boyu Sun; Dandan Li; Xuzhen Qin; Ling Qiu; Haitao Zhao
err分享
err收藏
Rescue of extreme hepatectomy mice by primary hepatocyte-derived 3D bio-printed organ transplantation极端肝切除术小鼠的拯救:原代肝细胞来源的3D生物打印器官移植
err2026-01-13
err0
errOAAI
errBao Jin; Zhibo Xie; Yinhan Wang; Yuce Lu; Lejia Sun; Zhangyuting He; Yuqian Ye; Zhiyuan Fang; Yarong Chi; Mingchang Pang; Changcan Li; Hang Sun; Zhuoran Danny Jiang; Xindi Ke; Haifeng Xu; Haitao Zhao; Xinting Sang; Shunda Du; Pengyu Huang; Huayu Yang; Yilei Mao
err分享
err收藏
FAD synthase confers ferroptosis resistance and restrains CD8+ T cell recruitment in hepatocellular carcinomaFAD synthase赋予铁死亡抗性并抑制肝细胞癌中CD8+ T细胞的募集
err2025-10-29
err0
errOAAI
errJiashuo Chao; Yuan Liang; Hao Wang; Ziyu Xun; Shanshan Wang; Zhengfeng Xuan; Mingming Wang; Qiyuan Huang; Rui Zhang; Mu Liu; Lei Zhang; Bohang Shou; Yuhan Zhang; Feng Cheng; Haitao Zhao; Ling Lu
err分享
err收藏
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial围手术期卡瑞利珠单抗联合瑞戈非尼 versus 手术单药治疗复发风险为中高危的可切除肝细胞癌患者(CARES-009):一项随机II/III期试验
err2025-10-19
err0
PREAI
errZheng Wang; Jia Fan; Shaolai Zhou; Yunfan Sun; Fei Liang; Yuan Ji; Fangming Gu; Tao Li; Li Peng; Tao Peng; Xiaolun Huang; Zhenbin Ding; Dousheng Bai; Bangde Xiang; Guang Tan; Tianfu Wen; Yongyi Zeng; Feng Han; Yu Zhang; Shengdong Wu; Haitao Zhao; Yi Chen; Guoming Shi; Zhiguo Hou; Ying Sun; Wenqing Zhu; Jian Zhou
err分享
err收藏
Local therapy overcomes primary resistance to target-immunotherapy combination in unresectable hepatocellular carcinoma局部治疗克服了不可切除肝癌中靶向-免疫治疗联合疗法的主要耐药性。
err2025-10-09
err0
errOAAI
errXiangqi Chen; Mingjian Piao; Zixiang Zhou; Shanshan Wang; Shuofeng Li; Nan Zhang; Boyu Sun; Kai Liu; Xu Yang; Xiaobo Yang; Xiaohua Shi; Chengpei Zhu; Haitao Zhao
err分享
err收藏
Adjuvant TACE Improves Prognosis After Resection in Dual-Phenotype Hepatocellular Carcinoma: A Propensity Score-Matched Study辅助TACE改善双表型肝癌切除后的预后:一项倾向性评分匹配研究
err2025-09-30
err0
errOAAI
errZijian Leng; Taifeng Zhu; Ziyue Huang; Xiaokun Chen; Yuce Lu; Yuehao Zhang; Xueshuai Wan; Xiaobo Yang; Lei Zhang; Haitao Zhao; Shunda Du; Zhonghai Zhao; Yongchang Zheng
err分享
err收藏
Immunotherapy change overcomes acquired resistance after chemo-immunotherapy in unresectable biliary tract cancer免疫疗法转换可克服不可切除性胆道癌化疗免疫疗法后的获得性耐药
err2025-09-29
err0
errOAAI
errXiangqi Chen; Zixiang Zhou; Shuofeng Li; Guanhua Yu; Shi Feng; Ze Zhou; Boyu Sun; Shanshan Wang; Kai Liu; Chengjie Li; Mingjian Piao; Mingming Wang; Yihong Zhang; Hu Li; Chengpei Zhu; Zhenyu Zhu; Haitao Zhao
err分享
err收藏